LNTH Q3 2018 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$89M+11.2% YoY

Gross Profit

$45M50.5% margin

Operating Income

$16M18.5% margin

Net Income

$9M10.4% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+3.9%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$425M

Total Liabilities

$369M

Stockholders' Equity

$56M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$80M	+11.2%
Gross Profit	$45M	$39M	+16.5%
Operating Income	$16M	$13M	+28.5%
Net Income	$9M	$9M	+8.7%

Revenue Segments

Product Revenue, Net

$88M99%

License and Royalty Revenues

$576,0001%